Audit of outcome of super-accelerated hepatitis B vaccination schedule in a genitourinary medicine clinic

International Journal of STD and AIDS

Volumn 16, Issue 9, 2005, Pages 636-637

  Jones, O ^a   Sankar, K N ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Genitourinary medicine clinics; Hepatitis B; Vaccination

Indexed keywords

RECOMBINANT HEPATITIS B VACCINE;

ARTICLE; HEPATITIS B; HUMAN; IMMUNE RESPONSE; INJECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; PRIORITY JOURNAL; SEROLOGY; TREATMENT OUTCOME; VACCINATION;

ADULT; FEMALE UROGENITAL DISEASES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION SCHEDULE; MALE UROGENITAL DISEASES; MEDICAL AUDIT; OUTPATIENT CLINICS, HOSPITAL; PATIENT COMPLIANCE; TREATMENT OUTCOME; VACCINATION;

EID: 25844510831     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462054944372     Document Type: Article

References (4)

1. Jaleel H, Allan PS, Huensberg M, Natin D. Offering the vaccine and accepting it: an audit of hepatitis B vaccination in West Midlands region. Int J STD AIDS 2003;14:632-5
2. Openeye AA, Bashford J. Audit of hepatitis B immunization at the genitourinary medicine department in Middlesbrough, UK. Int J STD AIDS 2002;13:268-70
3. Department of Health. The National Strategy for Sexual Health and HIV. London: DoH, 2001
4. Marchou B, Excler J-L, Bourderioux C, et al. A 3-week hepatitis B vaccination schedule provides rapid and persistent protective immunity: a multicenter, randomized trial comparing accelerated and classic vaccination schedules. J Infect Dis 1995;172:258-60